Metronidazole exhibits no clastogenic activity in a double-blind cross-over study on Crohn's patients
Open Access
- 28 June 2008
- journal article
- research article
- Published by Springer Nature in Hereditas
- Vol. 96 (2) , 279-286
- https://doi.org/10.1111/j.1601-5223.1982.tb00859.x
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- The mutagenicity of nitroaromatic drugsMutation Research/Genetic Toxicology, 1980
- The quantitative response of human tumours to radiation and misonidazoleBritish Journal of Cancer, 1979
- Lack of Evidence for Cancer Due to Use of MetronidazoleNew England Journal of Medicine, 1979
- Absence of chromosomal damage in the lymphocytes of patients treated with metronidazole for Trichomoniasis vaginalisToxicology Letters, 1979
- Metronidazole exhibits no cytogenetic effect in the micronucleus test in mice or on human lymphocytes in vitroMutation Research/Genetic Toxicology, 1979
- Absence of genotoxic effects of metronidazole and two of its urinary metabolites on human lymphocytes in vitroMutation Research/Genetic Toxicology, 1979
- The action of metronidazole on DNAJournal of Antimicrobial Chemotherapy, 1977
- Development of a Crohn's Disease Activity IndexGastroenterology, 1976
- The mode of action of metronidazole in Trichomonas vaginalis and other micro-organismsBiochemical Pharmacology, 1974
- The metabolism of metronidazole (1 -2′-hydroxyethyl-2-methyl-5-nitroimidazole)Biochemical Pharmacology, 1966